Intra-Articular Injection of Autologous Micro-Fragmented Adipose Tissue for the Treatment of Knee Osteoarthritis: A Prospective Interventional Study

Background: To investigate the efficacy and safety of autologous micro-fragmented adipose tissue (MF-AT) for improving joint function and cartilage repair in patients with knee osteoarthritis. Methods: From March 2019 to December 2020, 20 subjects (40 knees) between 50 and 65 years old suffering from knee osteoarthritis were enrolled in the study and administered a single injection of autologous MF-A. The data of all patients were prospectively collected. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), knee society score (KSS), hospital for special surgery (HSS) score, visual analogue score (VAS) pain score, changes in cartilage Recht grade on magnetic resonance imaging (MRI) and adverse events were analyzed before and 3, 6, 9, 12 and 18 months after injection. Results: The WOMAC, VAS, KSS and HSS scores at 3, 6, 9, 12 and 18 months after injection were improved compared with those before injection (p < 0.05). There was no significant difference in WOMAC scores between 9 and 12 months after injection (p > 0.05), but the WOMAC score 18 months after injection was worse than that at the last follow-up (p < 0.05). The VAS, KSS and HSS scores 9, 12 and 18 months after injection were worse than those at the last follow-up (p < 0.05). The Recht score improvement rate was 25%. No adverse events occurred during the follow-up. Conclusions: Autologous MF-AT improves knee function and relieves pain with no adverse events. However, the improved knee function was not sustained, with the best results occurring 9–12 months after injection and the cartilage regeneration remaining to be investigated.

[1]  L. Sconfienza,et al.  Micro-fragmented adipose tissue (mFAT) associated with arthroscopic debridement provides functional improvement in knee osteoarthritis: a randomized controlled trial , 2022, Knee Surgery, Sports Traumatology, Arthroscopy.

[2]  Junchao Luo,et al.  The Effect of Autologous Adipose-Derived Stromal Vascular Fractions on Cartilage Regeneration Was Quantitatively Evaluated Based on the 3D-FS-SPGR Sequence: A Clinical Trial Study , 2022, BioMed research international.

[3]  V. Iacono,et al.  The use of intra-articular injection of autologous micro-fragmented adipose tissue as pain treatment for ankle osteoarthritis: a prospective not randomized clinical study , 2021, International Orthopaedics.

[4]  G. Malanga,et al.  Clinical evaluation of micro-fragmented adipose tissue as a treatment option for patients with meniscus tears with osteoarthritis: a prospective pilot study , 2020, International Orthopaedics.

[5]  A. Gelber,et al.  Osteoarthritis , 2020, Annals of Internal Medicine.

[6]  K. Barfod,et al.  Treatment of osteoarthritis with autologous and microfragmented adipose tissue. , 2019, Danish medical journal.

[7]  Kirk A Easley,et al.  Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis , 2019, Stem cells translational medicine.

[8]  D. Primorac,et al.  Immunophenotyping of a Stromal Vascular Fraction from Microfragmented Lipoaspirate Used in Osteoarthritis Cartilage Treatment and Its Lipoaspirate Counterpart , 2019, Genes.

[9]  C. Bao,et al.  Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial , 2019, Stem Cell Research & Therapy.

[10]  I. Jonkers,et al.  Topographical Variation of Human Femoral Articular Cartilage Thickness, T1rho and T2 Relaxation Times Is Related to Local Loading during Walking , 2019, Cartilage.

[11]  Gi Beom Kim,et al.  Intra‐Articular Injection of Autologous Adipose Tissue‐Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo‐Controlled Clinical Trial , 2019, Stem cells translational medicine.

[12]  T. Pincus,et al.  Update on imaging in rheumatic diseases. , 2018, Clinical and experimental rheumatology.

[13]  Tadahiro Sakai,et al.  Relationship between patellar mobility and patellofemoral joint cartilage degeneration after anterior cruciate ligament reconstruction , 2017, Nagoya journal of medical science.

[14]  H. Shim,et al.  Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A 2-Year Follow-up Study , 2017, The American journal of sports medicine.

[15]  C. Ventura,et al.  Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development , 2016, Current Stem Cell Reports.

[16]  F. Rannou,et al.  Risk factors and burden of osteoarthritis. , 2016, Annals of physical and rehabilitation medicine.

[17]  K. Horan,et al.  Non-Responsive Knee Pain with Osteoarthritis and Concurrent Meniscal Disease Treated With Autologous Micro-Fragmented Adipose Tissue Under Continuous Ultrasound Guidance , 2015 .

[18]  F. Davatchi,et al.  Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients , 2016, International journal of rheumatic diseases.

[19]  G. Banfi,et al.  Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability , 2016, Stem cells international.

[20]  J. García-Sancho,et al.  Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial , 2015, Transplantation.

[21]  I. Sekiya,et al.  Arthroscopic Transplantation of Synovial Stem Cells Improves Clinical Outcomes in Knees With Cartilage Defects , 2015, Clinical orthopaedics and related research.

[22]  G. Burmester,et al.  Non-surgical management of knee osteoarthritis: where are we now and where do we need to go? , 2015, RMD Open.

[23]  J. García-Sancho,et al.  Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. , 2014, Transplantation.

[24]  H. Shim,et al.  Intra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical Trial , 2014, Stem cells.

[25]  M. Reijman,et al.  Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. , 2013, Osteoarthritis and cartilage.

[26]  Ana Sánchez,et al.  Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells: A Pilot Study , 2013, Transplantation.

[27]  Daniel Prieto-Alhambra,et al.  Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints , 2013, Annals of the rheumatic diseases.

[28]  N. Maffulli,et al.  Stem cell therapy for human cartilage defects: a systematic review. , 2013, Osteoarthritis and cartilage.

[29]  T. Miyazaki,et al.  Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis , 2012, Arthritis Research & Therapy.

[30]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[31]  D. Findlay.  If good things come from above, do bad things come from below? , 2010, Arthritis research & therapy.

[32]  J. Deprest,et al.  Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine , 2009, BJOG : an international journal of obstetrics and gynaecology.

[33]  Z. Cui,et al.  Adipose-derived stem cell: A better stem cell than BMSC , 2008, Cell Research.

[34]  J. Hui,et al.  Injectable Mesenchymal Stem Cell Therapy for Large Cartilage Defects—A Porcine Model , 2007, Stem cells.

[35]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. , 2007, Osteoarthritis and cartilage.

[36]  Frank P Barry,et al.  Stem cell therapy in a caprine model of osteoarthritis. , 2003, Arthritis and rheumatism.

[37]  Kenneth Dixon,et al.  Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. , 2002, Arthritis and rheumatism.

[38]  G. Mineo,et al.  Injection of autologous micro-fragmented adipose tissue for the treatment of post-traumatic degenerative lesion of knee cartilage: a case report , 2016 .

[39]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .